{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:53:27Z","timestamp":1762430007888},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,8,16]],"date-time":"2005-08-16T00:00:00Z","timestamp":1124150400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1038\/sj.bjc.6602742","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T07:49:12Z","timestamp":1124264952000},"page":"557-564","source":"Crossref","is-referenced-by-count":121,"title":["Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-\u03b1 and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression"],"prefix":"10.1038","volume":"93","author":[{"given":"H","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sakon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Damdinsuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Marubashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Dono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Umeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Monden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,16]]},"reference":[{"key":"BF6602742_CR1","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1890::AID-CNCR8>3.0.CO;2-K","volume":"79","author":"E Ando","year":"1997","unstructured":"Ando E, Yamashita F, Tanaka M, Tanikawa K (1997) A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer 79: 1890\u20131896","journal-title":"Cancer"},{"key":"BF6602742_CR2","first-page":"1862","volume":"46","author":"T Asahara","year":"1999","unstructured":"Asahara T, Itamoto T, Katayama K, Nakahara H, Hino H, Yano M, Ono E, Dohl K, Nakanishi T, Kitamoto M, Azuma K, Itoh K, Shimamoto F (1999) Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculature. Hepatogastroenterology 46: 1862\u20131869","journal-title":"Hepatogastroenterology"},{"key":"BF6602742_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","volume":"178","author":"V Brinkmann","year":"1993","unstructured":"Brinkmann V, Geiger T, Alkan S, Heusser CH (1993) Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 178: 1655\u20131663","journal-title":"J Exp Med"},{"key":"BF6602742_CR4","doi-asserted-by":"crossref","unstructured":"Cancer of Liver Italian Program (CLIP) investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28: 751\u2013755","DOI":"10.1002\/hep.510280322"},{"key":"BF6602742_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1746.1994.tb01207.x","volume":"9","author":"SC Chen","year":"1994","unstructured":"Chen SC, Hsieh MY, Chuang WL, Wang LY, Chang WY (1994) Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization. J Gastroenterol Hepatol 9: 1\u20136","journal-title":"J Gastroenterol Hepatol"},{"key":"BF6602742_CR6","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I","volume":"88","author":"YH Chung","year":"2000","unstructured":"Chung YH, Song IH, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ (2000) Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon \u2013 for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88: 1986\u20131991","journal-title":"Cancer"},{"key":"BF6602742_CR7","first-page":"114","volume":"58","author":"M Ciaparrone","year":"1998","unstructured":"Ciaparrone M, Yamamoto H, Yao Y, Sgambato A, Cattoretti G, Tomita N, Monden T, Rotterdam H, Weinstein IB (1998) Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Cancer Res 58: 114\u2013122","journal-title":"Cancer Res"},{"key":"BF6602742_CR8","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1245\/ASO.2003.03.010","volume":"10","author":"B Damdinsuren","year":"2003","unstructured":"Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, Umeshita K, Dono K, Nakamori S, Monden M (2003) Interferon-\u03b2 is more potent than interferon-\u03b1 in human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs. Ann Surg Oncol 10: 1184\u20131190","journal-title":"Ann Surg Oncol"},{"key":"BF6602742_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"3","author":"JE Darnell Jr","year":"1994","unstructured":"Darnell Jr JE, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 3: 1415\u20131421","journal-title":"Science"},{"key":"BF6602742_CR10","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1002\/1097-0142(19880515)61:10<1983::AID-CNCR2820611009>3.0.CO;2-V","volume":"61","author":"R Doci","year":"1988","unstructured":"Doci R, Bignami P, Bozzetti F, Bonfanti G, Audisio R, Colombo M, Gennari L (1988) Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer 61: 1983\u20131987","journal-title":"Cancer"},{"key":"BF6602742_CR11","first-page":"2881","volume":"6","author":"H Eguchi","year":"2000","unstructured":"Eguchi H, Nagano H, Yamamoto H, Miyamoto A, Kondo M, Dono K, Nakamori S, Umeshita K, Sakon M, Monden M (2000) Augmentation of anti-tumor activity of 5-FU by IFN-\u03b1 is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells. Clin Cancer Res 6: 2881\u20132890","journal-title":"Clin Cancer Res"},{"key":"BF6602742_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1386-6346(02)00312-1","volume":"25","author":"D Fujiwara","year":"2003","unstructured":"Fujiwara D, Hino K, Yamaguchi Y, Ren F, Satoh Y, Korenaga M, Okuda M, Okita K (2003) Hepatic expression of type I interferon receptor of predicting response to interferon therapy in chronic hepatitis C patients: a comparison of immuno-histochemical methods vs competitive polymerase chain reaction assay. Hepatol Res 25: 377\u2013384","journal-title":"Hepatol Res"},{"key":"BF6602742_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1148\/radiology.204.3.9280260","volume":"204","author":"J Furuse","year":"1997","unstructured":"Furuse J, Iwasaki M, Yoshino M, Konishi M, Kawano N, Kinoshita T, Ryu M, Satake M, Moriyama N (1997) Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 204: 787\u2013790","journal-title":"Radiology"},{"key":"BF6602742_CR14","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/0959-8049(93)90448-O","volume":"29A","author":"D Grander","year":"1993","unstructured":"Grander D, Xu B, Einhorn S (1993) Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies. Eur J Cancer 29A: 1940\u20131943","journal-title":"Eur J Cancer"},{"key":"BF6602742_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/jnci\/81.7.502","volume":"81","author":"F Guadagni","year":"1989","unstructured":"Guadagni F, Schlom J, Johnston WW, Szpak CA, Goldstein D, Smalley R, Simpson JF, Borden EC, Pestka S, Greiner JW (1989) Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells. J Natl Cancer Inst 81: 502\u2013512","journal-title":"J Natl Cancer Inst"},{"key":"BF6602742_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcb.240500102","volume":"50","author":"A Kimchi","year":"1992","unstructured":"Kimchi A (1992) Cytokine triggered molecular pathways that control cell cycle arrest. J Cell Biochem 50: 1\u20139","journal-title":"J Cell Biochem"},{"key":"BF6602742_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N","volume":"91","author":"Y Koike","year":"2001","unstructured":"Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Yoshida H, Shiina S, Omata M (2001) Des-gamma-carboxy prothrombin as a useful predisposing factors for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 91: 561\u2013569","journal-title":"Cancer"},{"key":"BF6602742_CR18","first-page":"83","volume":"17","author":"M Kondo","year":"2000","unstructured":"Kondo M, Nagano H, Sakon M, Yamamoto H, Morimoto O, Arai I, Miyamoto A, Eguchi H, Dono K, Nakamori S, Umeshita K, Wakasa K, Ohmoto Y, Monden M (2000) Expression of interferon \u03b1\/\u03b2 receptor in human hepatocellular carcinoma. Int J Oncol 17: 83\u201388","journal-title":"Int J Oncol"},{"key":"BF6602742_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-05-0274","volume":"11","author":"M Kondo","year":"2005","unstructured":"Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M (2005) Combination of interferon alpha and 5-fluorouracil induces apoptosis through interferon alpha\/beta receptor in human hepatocellular carcinoma cells. Clin Cancer Res 11: 1277\u20131286","journal-title":"Clin Cancer Res"},{"key":"BF6602742_CR20","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1158\/1078-0432.CCR-04-0243","volume":"10","author":"Y Kurokawa","year":"2004","unstructured":"Kurokawa Y, Matoba M, Nagano H, Sakon M, Takemasa I, Nakamori S, Dono K, Umeshita K, Ueno N, Ishii S, Kato K, Monden M (2004) Molecular prediction of response to 5-fluorouracil and interferon-\u03b1 combination chemotherapy in advanced hepatocellular carcinoma. Clin Cancer Res 10: 6029\u20136038","journal-title":"Clin Cancer Res"},{"key":"BF6602742_CR21","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2087::AID-CNCR5>3.0.CO;2-M","volume":"79","author":"HS Lee","year":"1997","unstructured":"Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: a prospective controlled study. Cancer 79: 2087\u20132094","journal-title":"Cancer"},{"key":"BF6602742_CR22","first-page":"1676","volume":"5","author":"TW Leung","year":"1999","unstructured":"Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ (1999) Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5: 1676\u20131681","journal-title":"Clin Cancer Res"},{"key":"BF6602742_CR23","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/gut.50.6.881","volume":"50","author":"I Levy","year":"2002","unstructured":"Levy I, Sherman M, the Liver Cancer Group of the University of Toronto (2002) Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child\u2013Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50: 881\u2013885","journal-title":"Gut"},{"key":"BF6602742_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1073\/pnas.69.3.721","volume":"69","author":"P Lindahl","year":"1972","unstructured":"Lindahl P, Leary R, Gresser I (1972) Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci USA 69: 721\u2013725","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6602742_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1046\/j.1440-1746.2000.02289.x","volume":"15","author":"A Miyamoto","year":"2000","unstructured":"Miyamoto A, Umeshita K, Sakon M, Nagano H, Eguchi H, Kishimoto S, Dono K, Nakamori S, Gotoh M, Monden M (2000) Advanced hepatocellular carcinoma with distant metastases, successfully treated by a combination therapy with (-interferon and oral tegaful\/uracil. J Gastroenterol Hepatol 15: 1447\u20131451","journal-title":"J Gastroenterol Hepatol"},{"key":"BF6602742_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","volume":"77","author":"D Novick","year":"1994","unstructured":"Novick D, Cohen B, Rubinstein M (1994) The human interferon alpha\/beta receptor: characterization and molecular cloning. Cell 77: 391\u2013400","journal-title":"Cell"},{"key":"BF6602742_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"BF6602742_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ijc.2910310306","volume":"31","author":"JR Ortaldo","year":"1983","unstructured":"Ortaldo JR, Mantovani A, Hobbs D, Rubinstein M, Pestka S, Herberman RB (1983) Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer 31: 285\u2013289","journal-title":"Int J Cancer"},{"key":"BF6602742_CR29","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1002\/1097-0142(19931101)72:9<2574::AID-CNCR2820720911>3.0.CO;2-L","volume":"72","author":"YZ Patt","year":"1993","unstructured":"Patt YZ, Yoffe B, Charnsangavej C, Pazdur R, Fischer H, Cleary K, Roh M, Smith R, Noonan CA, Levin B (1993) Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha- 2b. Cancer 72: 2574\u20132582","journal-title":"Cancer"},{"key":"BF6602742_CR30","first-page":"376","volume":"237","author":"RT Poon","year":"2003","unstructured":"Poon RT, Fan ST, Ng IO, Wong J (2003) Prognosis after hepatic resection for Stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 237: 376\u2013383","journal-title":"Ann Surg"},{"key":"BF6602742_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cncr.10246","volume":"94","author":"M Sakon","year":"2002","unstructured":"Sakon M, Nagano H, Dono K, Nakamori S, Umeshita K, Yamada A, Kawata S, Imai Y, Iijima S, Monden M (2002) Combined intraarterial 5-fuluorouracil and subcutaneous interferon-\u03b1 therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 94: 435\u2013442","journal-title":"Cancer"},{"key":"BF6602742_CR32","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1038\/sj.onc.1202609","volume":"18","author":"O Sangfelt","year":"1999","unstructured":"Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grander D (1999) Molecular mechanisms underlying interferon-alpha-induced G0\/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 18: 2798\u20132810","journal-title":"Oncogene"},{"key":"BF6602742_CR33","first-page":"425","volume":"323","author":"EL Schwartz","year":"1992","unstructured":"Schwartz EL, Hoffman M, O'Conneor CJ, Wadler S (1992) Stimulation of 5-Fluorouracil metabolic activation by interferon-\u03b1 in human colon carcinoma cells. Biochem Biophys Res Commun 323: 425\u2013428","journal-title":"Biochem Biophys Res Commun"},{"key":"BF6602742_CR34","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01850","volume":"424","author":"A Takaoka","year":"2003","unstructured":"Takaoka A, Hayakawa S, Yanai H, Stoiben D, Negishi H, Kikuchi H, Sasaki S, Imai K, Shibue T, Honda K, Taniguchi T (2003) Integration of interferon-\u03b1\/signaling to p53 responses in tumour suppression and antiviral defence. Nature 424: 516\u2013523","journal-title":"Nature"},{"key":"BF6602742_CR35","first-page":"621","volume":"6","author":"A Takayama","year":"2000","unstructured":"Takayama A, Yano H, Ogasawara S, Higaki K, Kojiro M (2000) Expression of Hu- IFN-\u03b1R2 chain of type I interferon receptor in human hepatocellular carcinoma and non-cancerous tissues. Int J Mol Med 6: 621\u2013627","journal-title":"Int J Mol Med"},{"key":"BF6602742_CR36","first-page":"637","volume":"43","author":"A Tanaka","year":"1996","unstructured":"Tanaka A, Morimoto T, Yamaoka Y (1996) Implications of surgical treatment for advanced hepatocellular carcinoma with tumor thrombi in the portal vein. Hepatogastroenterology 43: 637\u2013643","journal-title":"Hepatogastroenterology"},{"key":"BF6602742_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000227477","volume":"52","author":"H Toyoda","year":"1995","unstructured":"Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Suga T, Takahashi M (1995) The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 52: 295\u2013299","journal-title":"Oncology"},{"key":"BF6602742_CR38","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4049\/jimmunol.120.6.1849","volume":"120","author":"G Trinchieri","year":"1978","unstructured":"Trinchieri G, Santoli D, Koprowski H (1978) Spontaneous cell-mediated cytotoxicity in humans; role of interferon and immunoglobulins. J Immunol 120: 1849\u20131855","journal-title":"J Immunol"},{"key":"BF6602742_CR39","first-page":"1320","volume":"45","author":"K Uno","year":"1985","unstructured":"Uno K, Shimizu S, Ido M, Naito K, Inaba K, Oku T, Kishida T, Muramatsu S (1985) Direct and indirect effects of interferon on in vivo murine tumor cell growth. Cancer Res 45: 1320\u20131327","journal-title":"Cancer Res"},{"key":"BF6602742_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000011833","volume":"55","author":"T Urabe","year":"1998","unstructured":"Urabe T, Kaneko S, Matsushita E, Unoura M, Kobayashi K (1998) Clinical pilot study of intrahepatic arterial chemotherapy with methotrexate, 5-fluorouracil, cisplatin and subcutaneous interferon-alpha-2b for patients with locally advanced hepatocellular carcinoma. Oncology 55: 39\u201347","journal-title":"Oncology"},{"key":"BF6602742_CR41","first-page":"3473","volume":"50","author":"S Wadler","year":"1990","unstructured":"Wadler S, Schwartz EL (1990) Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50: 3473\u20133486","journal-title":"Cancer Res"},{"key":"BF6602742_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ijc.20236","volume":"111","author":"TC Wagner","year":"2004","unstructured":"Wagner TC, Velichko S, Chesney SK, Biroc S, Harde D, Vogel D, Croze E (2004) Interferon receptor expression regulates the antiproliferative effects of interferon on cancer cells and solid tumors. Int J Cancer 111: 32\u201342","journal-title":"Int J Cancer"},{"key":"BF6602742_CR43","unstructured":"WHO handbook for reporting results of cancer treatment (1979) World Health Organization Offset Publication No 48. Geneva: Switzerland"},{"key":"BF6602742_CR44","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0168-8278(99)80197-4","volume":"30","author":"K Yamakado","year":"1999","unstructured":"Yamakado K, Tanaka N, Nakatsuka A, Matsumura K, Takase K, Takeda K (1999) Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein. J Hepatol 30: 660\u2013668","journal-title":"J Hepatol"},{"key":"BF6602742_CR45","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1158\/1078-0432.CCR-04-0794","volume":"10","author":"T Yamamoto","year":"2004","unstructured":"Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Yamamoto H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M (2004) Partial contribution of TRAIL\/TRAIL receptor pathway to anti-tumor effects of IFN-\u03b1\/5-FU against hepatocellular carcinoma. Clin Cancer Res 10: 7884\u20137895","journal-title":"Clin Cancer Res"},{"key":"BF6602742_CR46","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.510290624","volume":"29","author":"H Yano","year":"1999","unstructured":"Yano H, Iemura A, Haramaki M, Ogasawara S, Takayama A, Akiba J, Kojiro M (1999) Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology 29: 1708\u20131717","journal-title":"Hepatology"},{"key":"BF6602742_CR47","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0168-8278(99)80252-9","volume":"30","author":"H Yatsuhashi","year":"1999","unstructured":"Yatsuhashi H, Fujino T, Matsumoto T, Inoue O, Koga M, Yano M (1999) Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol 30: 995\u20131003","journal-title":"J Hepatol"},{"key":"BF6602742_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1440-1746.1995.tb01086.x","volume":"10","author":"FS Yen","year":"1995","unstructured":"Yen FS, Wu JC, Kuo BI, Chiang JH, Chen TZ, Lee SD (1995) Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis. J Gastroenterol Hepatol 10: 237\u2013240","journal-title":"J Gastroenterol Hepatol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602742","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602742.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:17:46Z","timestamp":1684412266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,16]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["BF6602742"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602742","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,16]]}}}